STOCK TITAN

Vanguard disaggregates holdings; reports 0% in AdaptHealth (AHCO)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

AdaptHealth Corp Schedule 13G/A amendment: The Vanguard Group reports no beneficial ownership of AdaptHealth Corp common stock, listing 0 shares and 0% of the class. The filing explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report separately.

The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026. The disclosure states Vanguard entities retain the right to receive dividends or proceeds for managed accounts but that no single third party holds more than 5% of the class under the reported arrangement.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings and reports zero beneficial ownership in this amendment.

The filing records an internal realignment dated January 12, 2026 and shows 0 shares and 0% beneficial ownership reported by The Vanguard Group for AdaptHealth Corp common stock. It notes that certain subsidiaries now report separately in reliance on SEC Release No. 34-39538.

Cash‑flow treatment and any prior holdings by disaggregated entities are not detailed in the excerpt; subsequent filings from the separate reporting entities would show any actual holdings.

The amendment documents compliance with the SEC disaggregation release and clarifies reporting structure.

The text cites SEC Release No. 34-39538 and states that certain subsidiaries ‘‘will report beneficial ownership separately.’b The signed amendment records the administrative change and reports no beneficial ownership by The Vanguard Group itself as of the filing.

Material implications depend on disclosures from those subsidiary filings; this amendment is administrative and does not by itself indicate a change in underlying economic ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the AdaptHealth (AHCO) Schedule 13G/A amendment report?

It reports that The Vanguard Group beneficially owns 0 shares of AdaptHealth common stock, representing 0% of the class, and describes an internal reporting realignment dated January 12, 2026.

Why does Vanguard say subsidiaries will report separately for AHCO?

Vanguard cites SEC Release No. 34-39538 and an internal realignment on January 12, 2026, stating certain subsidiaries/business divisions will disaggregate and report beneficial ownership separately going forward.

Does this filing show any Vanguard entity holds more than 5% of AHCO?

No. The filing states no one other person's interest reported here is more than 5% of the class and shows 0% for The Vanguard Group in this amendment.

Who signed the Schedule 13G/A for Vanguard on the AHCO filing?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/26/2026.

Does this amendment disclose cash proceeds or transactions for AHCO shares?

No. The amendment reports ownership figures and the reporting realignment; it does not disclose any cash proceeds, purchases, or sales tied to AdaptHealth common stock.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026